Cases keep increasing: 819 cases and 516 deaths have been reported as of 11 February. This is the largest-ever Ebola virus disease outbreak in the Democratic Republic of the Congo and the second largest in history.
Ebola vaccine candidates are currently being evaluated in phase I–III clinical trials conducted in Africa, the EU and the US. An experimental vaccine has shown to be safe and protective against the Zaire strain of the Ebola virus. It was approved for “compassionate use” in the ongoing Ebola outbreak in DRC.